Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo- and Active-Controlled Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain

NCT00838799 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00838799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00838799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain
Lead sponsor
Forest Laboratories
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
Not reported
Enrollment
458 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathic pain